Skip to main content
‘Major advance’: Sotorasib benefit persists in KRAS+ NSCLC
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
‘Major advance’: Sotorasib benefit persists in KRAS+ NSCLC
User login
Username
Password
Reset your password
Concept
Lead
score
Lung Cancer
1
1
Genomic Medicine
0
0.76
Non-Small Cell Lung Cancer
0
0.99
Biologic Therapy
0
0.68
KRAS
0
0.67
Colorectal Cancer
0
0.65
Cancer
0
0.6
Small Cell Lung Cancer
0
0.47
Tumor
0
0.27
Clinical Research
0
0.14
Drug Resistance
0
0.14
Europe
0
0.14
Lung
0
0.14
Scan
0
0.14
Hemolytic Anemia
0
0.1
Medical Life
0
0.09
Anemia
0
0.07
Chemotherapy
0
0.07
Immunotherapy
0
0.07
Match
0
0.07
Medical Oncology
0
0.07
Oncogene
0
0.07
Platinum
0
0.07
Prognosis
0
0.07
Texas
0
0.07
Specialty
Lead
score
Hematology-Oncology
1
1
Internal Medicine
0
0.8
Pulmonary Medicine
0
0.9
Edit Tags